Summit Therapeutics plc Summit Therapeutics Plc : Exercise Of Options
15 October 2016 - 2:20AM
UK Regulatory
TIDMSUMM
Summit Therapeutics plc
("Summit" or the "Company")
EXERCISE OF SHARE OPTIONS
Oxford, UK, 14 October 2016 - Summit Therapeutics plc (AIM: SUMM,
NASDAQ: SMMT), the drug discovery and development company advancing
therapies for Duchenne muscular dystrophy and C. difficile infection,
announces that, following the exercise of employee share options, the
Company has issued 3,560 new ordinary shares of 1p each (the "New
Ordinary Shares").
Application has been made for the admission to trading on AIM of the New
Ordinary Shares, which will rank pari passu with the Company's existing
ordinary shares, and admission is expected to occur on or around 20
October 2016.
Following admission of the New Ordinary Shares to trading on AIM, the
total number of ordinary shares with voting rights in issue will be
61,804,316. This figure may be used by shareholders as the denominator
for the calculations by which they will determine if they are required
to notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure and Transparency Rules.
This announcement contains inside information for the purposes of
Article 7 of EU Regulation 596/2014.
- END -
For more information, please contact:
Summit Therapeutics
Richard Pye (UK office) Tel: +44 (0)1235 443 951
Erik Ostrowski (US office) +1 617 294 6607
Cairn Financial Advisers LLP
(Nominated Adviser) Tel: +44 (0)20 7148 7900
Liam Murray / Tony Rawlinson
This announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the information
contained therein.
Source: Summit Therapeutics plc via Globenewswire
http://www.summitplc.com/
(END) Dow Jones Newswires
October 14, 2016 11:20 ET (15:20 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Summit Therapeutics (LSE:SUMM)
Historical Stock Chart
From Apr 2024 to May 2024
Summit Therapeutics (LSE:SUMM)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Summit Therapeutics Plc (London Stock Exchange): 0 recent articles
More Summit Ther News Articles